Switch theme
Sign up to access all valuation multiples
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives its maximum revenue from the Jawa segment.
1999
17.6K+
LTM Revenue $431M
LTM EBITDA $118M
$1.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Hermina Hospitals has a last 12-month revenue (LTM) of $431M and a last 12-month EBITDA of $118M.
In the most recent fiscal year, Hermina Hospitals achieved revenue of $413M and an EBITDA of $82.6M.
Hermina Hospitals expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Hermina Hospitals valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $431M | XXX | $413M | XXX | XXX | XXX |
| Gross Profit | $157M | XXX | $151M | XXX | XXX | XXX |
| Gross Margin | 36% | XXX | 36% | XXX | XXX | XXX |
| EBITDA | $118M | XXX | $82.6M | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 20% | XXX | XXX | XXX |
| EBIT | $67.7M | XXX | $64.8M | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $35.7M | XXX | $32.9M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $158M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Hermina Hospitals's stock price is IDR 1540 (or $0).
Hermina Hospitals has current market cap of IDR 22.93T (or $1.4B), and EV of IDR 25.68T (or $1.6B).
See Hermina Hospitals trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.6B | $1.4B | XXX | XXX | XXX | XXX | $0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Hermina Hospitals has market cap of $1.4B and EV of $1.6B.
Hermina Hospitals's trades at 3.8x EV/Revenue multiple, and 19.1x EV/EBITDA.
Equity research analysts estimate Hermina Hospitals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Hermina Hospitals has a P/E ratio of 39.4x.
See valuation multiples for Hermina Hospitals and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV (current) | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
| EV/Revenue | 3.7x | XXX | 3.8x | XXX | XXX | XXX |
| EV/EBITDA | 13.4x | XXX | 19.1x | XXX | XXX | XXX |
| EV/EBIT | 23.3x | XXX | 24.3x | XXX | XXX | XXX |
| EV/Gross Profit | 10.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 39.4x | XXX | 42.8x | XXX | XXX | XXX |
| EV/FCF | -42.1x | XXX | -22.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHermina Hospitals's last 12 month revenue growth is 11%
Hermina Hospitals's revenue per employee in the last FY averaged $23K, while opex per employee averaged $5K for the same period.
Hermina Hospitals's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hermina Hospitals's rule of X is 55% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Hermina Hospitals and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 37% | XXX | XXX | XXX |
| Rule of 40 | 30% | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 55% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $23K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $5K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 21% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hermina Hospitals acquired XXX companies to date.
Last acquisition by Hermina Hospitals was XXXXXXXX, XXXXX XXXXX XXXXXX . Hermina Hospitals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Hermina Hospitals founded? | Hermina Hospitals was founded in 1999. |
| Where is Hermina Hospitals headquartered? | Hermina Hospitals is headquartered in Indonesia. |
| How many employees does Hermina Hospitals have? | As of today, Hermina Hospitals has 17.6K+ employees. |
| Is Hermina Hospitals publicy listed? | Yes, Hermina Hospitals is a public company listed on IDX. |
| What is the stock symbol of Hermina Hospitals? | Hermina Hospitals trades under HEAL ticker. |
| When did Hermina Hospitals go public? | Hermina Hospitals went public in 2018. |
| Who are competitors of Hermina Hospitals? | Similar companies to Hermina Hospitals include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Hermina Hospitals? | Hermina Hospitals's current market cap is $1.4B |
| What is the current revenue of Hermina Hospitals? | Hermina Hospitals's last 12 months revenue is $431M. |
| What is the current revenue growth of Hermina Hospitals? | Hermina Hospitals revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Hermina Hospitals? | Current revenue multiple of Hermina Hospitals is 3.7x. |
| Is Hermina Hospitals profitable? | Yes, Hermina Hospitals is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Hermina Hospitals? | Hermina Hospitals's last 12 months EBITDA is $118M. |
| What is Hermina Hospitals's EBITDA margin? | Hermina Hospitals's last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Hermina Hospitals? | Current EBITDA multiple of Hermina Hospitals is 13.4x. |
| What is the current FCF of Hermina Hospitals? | Hermina Hospitals's last 12 months FCF is -$37.4M. |
| What is Hermina Hospitals's FCF margin? | Hermina Hospitals's last 12 months FCF margin is -9%. |
| What is the current EV/FCF multiple of Hermina Hospitals? | Current FCF multiple of Hermina Hospitals is -42.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
